The Effect of Chelation on Blood Pressure in Lead-Exposed Children
Author Information
Author(s): Chen Aimin, Rhoads George G., Cai Bo, Salganik Mikhail, Rogan Walter J.
Primary Institution: National Institute of Environmental Health Sciences
Hypothesis
Does succimer chelation therapy affect blood pressure in children with elevated blood lead levels?
Conclusion
Succimer treatment did not change blood pressure in children with moderately high lead exposure.
Supporting Evidence
- Children in the succimer group had lower blood lead concentrations for 9–10 months during and after treatment.
- There was no difference in blood pressure between the succimer and placebo groups during the treatment period.
- Over 5 years, children in the succimer group had a 1.09 mmHg higher systolic blood pressure compared to untreated children.
Takeaway
The study looked at whether a medicine called succimer could help lower blood pressure in kids who had too much lead in their blood, but it didn't make a difference.
Methodology
A randomized, placebo-controlled, double-blind clinical trial comparing blood pressure in children treated with succimer versus placebo over 5 years.
Potential Biases
Potential residual confounding factors such as genetics and dietary intake.
Limitations
The study may not have enough power to detect small differences in blood pressure due to lead exposure.
Participant Demographics
44% female, 77% African American, 72% lived with a single parent, 40% had parents with < 12 years of education.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI, 0.27–1.90 mmHg
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website